{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:55:47Z","timestamp":1777535747693,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI095789"],"award-info":[{"award-number":["R01AI095789"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI11\/00423"],"award-info":[{"award-number":["PI11\/00423"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/01422"],"award-info":[{"award-number":["PI14\/01422"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"AGAUR","doi-asserted-by":"crossref","award":["2014 SGR991"],"award-info":[{"award-number":["2014 SGR991"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Health Department Catalan Government","award":["SLT006\/17\/00109"],"award-info":[{"award-number":["SLT006\/17\/00109"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12916-019-1378-6","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T21:02:16Z","timestamp":1565730136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["RTS,S\/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6751-4060","authenticated-orcid":false,"given":"Carlota","family":"Doba\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itziar","family":"Ubillos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenjerai","family":"Jairoce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Gyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfons","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebeca","family":"Santano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Dosoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto J.","family":"Nhabomba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aintzane","family":"Ayestaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana Aba","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"D\u00edez-Padrisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lanar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virander","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chetan","family":"Chitnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheetij","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Gaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelina","family":"Angov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwaku Poku","family":"Asante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth","family":"Owusu-Agyei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa","family":"Valim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Gamain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross L.","family":"Coppel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Beeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Moncunill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,14]]},"reference":[{"issue":"171","key":"1378_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/jamapediatrics.2017.0638","volume":"2017","author":"M Voysey","year":"2017","unstructured":"Voysey M, Kelly DF, Fanshawe TR, Sadarangani M, O\u2019Brien KL, Perera R, et al. The influence of maternally derived antibody and infant age at vaccination on infant vaccine responses: an individual participant meta-analysis. JAMA Pediatr. 2017;2017(171):637\u201346. \n                    https:\/\/doi.org\/10.1001\/jamapediatrics.2017.0638\n                    \n                  .","journal-title":"JAMA Pediatr"},{"key":"1378_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1128\/CMR.00025-08","volume":"22","author":"DL Doolan","year":"2009","unstructured":"Doolan DL, Doba\u00f1o C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev. 2009;22:13\u201336. \n                    https:\/\/doi.org\/10.1128\/CMR.00025-08\n                    \n                  .","journal-title":"Clin Microbiol Rev"},{"key":"1378_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/192733a0","volume":"192","author":"S Cohen","year":"1961","unstructured":"Cohen S, McGregor I, Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature. 1961;192:733\u20137. \n                    https:\/\/doi.org\/10.1038\/192733a0\n                    \n                  .","journal-title":"Nature."},{"key":"1378_CR4","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1056\/NEJMoa1102287","volume":"365","author":"ST Agnandji","year":"2011","unstructured":"Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BP, Conzelmann C, et al. First results of phase 3 trial of RTS,S\/AS01 malaria vaccine in African children. N Engl J Med. 2011;365:1863\u201375. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1102287\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1378_CR5","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1056\/NEJMoa1208394","volume":"367","author":"ST Agnandji","year":"2012","unstructured":"Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BGNO, Kabwende AL, et al. A phase 3 trial of RTS,S\/AS01 malaria vaccine in African infants. N Engl J Med. 2012;367:2284\u201395. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1208394\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1378_CR6","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/S1473-3099(15)00239-X","volume":"15","author":"MT White","year":"2015","unstructured":"White MT, Verity R, Griffin JT, Asante KP, Owusu-Agyei S, Greenwood B, et al. Immunogenicity of the RTS,S\/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. Lancet Infect Dis. 2015;15:1450\u20138. \n                    https:\/\/doi.org\/10.1016\/S1473-3099(15)00239-X\n                    \n                  .","journal-title":"Lancet Infect Dis"},{"key":"1378_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1186-4","volume":"16","author":"I Ubillos","year":"2018","unstructured":"Ubillos I, Ayestaran A, Nhabomba AJ, Dosoo D, Vidal M, Jimenez A, et al. Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S\/AS01E vaccination in African children. BMC Med. 2018;16:197. \n                    https:\/\/doi.org\/10.1186\/s12916-018-1186-4\n                    \n                  .","journal-title":"BMC Med"},{"key":"1378_CR8","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","volume":"364","author":"PL Alonso","year":"2004","unstructured":"Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Milman J, et al. Efficacy of the RTS,S\/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet. 2004;364:1411\u201320. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(04)17223-1\n                    \n                  .","journal-title":"Lancet."},{"key":"1378_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1086\/600119","volume":"200","author":"J Sacarlal","year":"2009","unstructured":"Sacarlal J, Aide P, Aponte JJ, Renom M, Leach A, Mandomando I, et al. Long-term safety and efficacy of the RTS,S\/AS02A malaria vaccine in Mozambican children. J Infect Dis. 2009;200:329\u201336. \n                    https:\/\/doi.org\/10.1086\/600119\n                    \n                  .","journal-title":"J Infect Dis"},{"key":"1378_CR10","doi-asserted-by":"publisher","first-page":"e5165","DOI":"10.1371\/journal.pone.0005165","volume":"4","author":"C Guinovart","year":"2009","unstructured":"Guinovart C, Aponte JJ, Sacarlal J, Aide P, Leach A, Bassat Q, et al. Insights into long-lasting protection induced by RTS,S\/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children. PLoS One. 2009;4:e5165. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0005165\n                    \n                  .","journal-title":"PLoS One"},{"key":"1378_CR11","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S0140-6736(02)09784-2","volume":"360","author":"DJ Pombo","year":"2002","unstructured":"Pombo DJ, Lawrence G, Hirunpetcharat C, Rzepczyk C, Bryden M, Cloonan N, et al. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet. 2002;360:610\u20137. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(02)09784-2\n                    \n                  .","journal-title":"Lancet."},{"issue":"10","key":"1378_CR12","doi-asserted-by":"publisher","first-page":"e25779","DOI":"10.1371\/journal.pone.0025779","volume":"6","author":"Joseph J. Campo","year":"2011","unstructured":"Campo JJ, Doba\u00f1o C, Sacarlal J, Guinovart C, Mayor A, Angov E, et al. Impact of the RTS,S malaria vaccine candidate on naturally acquired antibody responses to multiple asexual blood stage antigens. PLoS One. 2011;6. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0025779\n                    \n                  .","journal-title":"PLoS ONE"},{"key":"1378_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1074\/mcp.M114.044677","volume":"14","author":"JJ Campo","year":"2015","unstructured":"Campo JJ, Aponte JJ, Skinner J, Nakajima R, Molina DM, Liang L, et al. RTS,S vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites. Mol Cell Proteomics. 2015;14:519\u201331. \n                    https:\/\/doi.org\/10.1074\/mcp.M114.044677\n                    \n                  .","journal-title":"Mol Cell Proteomics"},{"key":"1378_CR14","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/cid\/cix429","volume":"65","author":"G Moncunill","year":"2017","unstructured":"Moncunill G, Mpina M, Nhabomba AJ, Aguilar R, Ayestaran A, Sanz H, et al. Distinct helper T cell type 1 and 2 responses associated with malaria protection and risk in RTS,S\/AS01E vaccinees. Clin Infect Dis. 2017;65:746\u201355. \n                    https:\/\/doi.org\/10.1093\/cid\/cix429\n                    \n                  .","journal-title":"Clin Infect Dis"},{"key":"1378_CR15","doi-asserted-by":"publisher","first-page":"e6083","DOI":"10.1371\/journal.pone.0006083","volume":"4","author":"L Stewart","year":"2009","unstructured":"Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R, et al. Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One. 2009;4:e6083. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0006083\n                    \n                  .","journal-title":"PLoS One"},{"key":"1378_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12936-018-2365-7","volume":"17","author":"I Ubillos","year":"2018","unstructured":"Ubillos I, Campo JJ, Jim\u00e9nez A, Doba\u00f1o C. Development of a high-throughput flexible quantitative suspension array assay for IgG against multiple Plasmodium falciparum antigens. Malar J. 2018;17:216. \n                    https:\/\/doi.org\/10.1186\/s12936-018-2365-7\n                    \n                  .","journal-title":"Malar J"},{"key":"1378_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jim.2018.01.009","volume":"455","author":"M Vidal","year":"2018","unstructured":"Vidal M, Aguilar R, Campo JJ, Doba\u00f1o C. Development of quantitative suspension array assays for six immunoglobulin isotypes and subclasses to multiple Plasmodium falciparum antigens. J Immunol Methods. 2018;455:41\u201354. \n                    https:\/\/doi.org\/10.1016\/j.jim.2018.01.009\n                    \n                  .","journal-title":"J Immunol Methods"},{"key":"1378_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12936-018-2369-3","volume":"17","author":"I Ubillos","year":"2018","unstructured":"Ubillos I, Jimenez A, Vidal M, Bowyer PW, Gaur D, Dutta S, et al. Optimization of incubation conditions of Plasmodium falciparum antibody multiplex assays to measure IgG, IgG1-4, IgM and IgE using standard and customized reference pools for sero-epidemiological and vaccine studies. Malar J. 2018;17:219. \n                    https:\/\/doi.org\/10.1186\/s12936-018-2369-3\n                    \n                  .","journal-title":"Malar J"},{"key":"1378_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-017-1958-x","volume":"16","author":"D Bryan","year":"2017","unstructured":"Bryan D, Silva N, Rigsby P, Dougall T, Corran P, Bowyer PW, et al. The establishment of a WHO reference reagent for anti-malaria (Plasmodium falciparum) human serum. Malar J. 2017;16:1\u201310. \n                    https:\/\/doi.org\/10.1186\/s12936-017-1958-x\n                    \n                  .","journal-title":"Malar J"},{"key":"1378_CR20","first-page":"65","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65\u201370 Available: \n                    http:\/\/www.jstor.org\/stable\/4615733\n                    \n                  .","journal-title":"Scand J Stat"},{"key":"1378_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v025.i01","volume":"25","author":"S Le","year":"2008","unstructured":"Le S, Josse J, Husson F. FactoMineR: an R package for multivariate analysis. J Stat Softw. 2008;25:1\u201318. \n                    https:\/\/doi.org\/10.18637\/jss.v025.i01\n                    \n                  .","journal-title":"J Stat Softw"},{"key":"1378_CR22","volume-title":"R package \u201ccorrplot\u201d: visualization of a correlation matrix (version 0.84)","author":"T Wei","year":"2017","unstructured":"Wei T, Simko V. R package \u201ccorrplot\u201d: visualization of a correlation matrix (version 0.84). 2017. Available: \n                    https:\/\/github.com\/taiyun\/corrplot\n                    \n                  ."},{"key":"1378_CR23","volume-title":"DiscriMiner: tools of the trade for discriminant analysis. R package version 0.1\u201329","author":"G Sanchez","year":"2013","unstructured":"Sanchez G. DiscriMiner: tools of the trade for discriminant analysis. R package version 0.1\u201329. 2013. Available: \n                    https:\/\/cran.r-project.org\/package=DiscriMiner"},{"key":"1378_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/infdis\/jir222","volume":"204","author":"P Bejon","year":"2011","unstructured":"Bejon P, Cook J, Bergmann-Leitner E, Olotu A, Lusingu J, Mwacharo J, et al. Effect of the pre-erythrocytic candidate malaria vaccine RTS,S\/AS01E on blood stage immunity in young children. J Infect Dis. 2011;204:9\u201318. \n                    https:\/\/doi.org\/10.1093\/infdis\/jir222\n                    \n                  .","journal-title":"J Infect Dis"},{"key":"1378_CR25","doi-asserted-by":"publisher","first-page":"20143085","DOI":"10.1098\/rspb.2014.3085","volume":"282","author":"AK Simon","year":"2015","unstructured":"Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proceedings Biol Sci. 2015;282:20143085. \n                    https:\/\/doi.org\/10.1098\/rspb.2014.3085\n                    \n                  .","journal-title":"Proceedings Biol Sci"},{"key":"1378_CR26","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1038\/s41598-017-05025-5","volume":"7","author":"A Valmaseda","year":"2017","unstructured":"Valmaseda A, Bassat Q, Aide P, Cistero P, Jimenez A, Casellas A, et al. Host age and expression of genes involved in red blood cell invasion in Plasmodium falciparum field isolates. Sci Rep. 2017;7:4717. \n                    https:\/\/doi.org\/10.1038\/s41598-017-05025-5\n                    \n                  .","journal-title":"Sci Rep"},{"key":"1378_CR27","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1016\/j.vaccine.2011.03.041","volume":"29","author":"P Aide","year":"2011","unstructured":"Aide P, Dobano C, Sacarlal J, Aponte JJ, Mandomando I, Guinovart C, et al. Four year immunogenicity of the RTS,S\/AS02(A) malaria vaccine in Mozambican children during a phase IIb trial. Vaccine. 2011;29:6059\u201367. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2011.03.041\n                    \n                  .","journal-title":"Vaccine."},{"key":"1378_CR28","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/S0140-6736(01)06957-4","volume":"358","author":"KA Bojang","year":"2001","unstructured":"Bojang KA, Milligan PJ, Pinder M, Vigneron L, Alloueche A, Kester KE, et al. Efficacy of RTS,S\/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in the Gambia: a randomised trial. Lancet. 2001;358:1927\u201334. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(01)06957-4\n                    \n                  .","journal-title":"Lancet."},{"key":"1378_CR29","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.vaccine.2014.02.042","volume":"32","author":"JJ Campo","year":"2014","unstructured":"Campo JJ, Sacarlal J, Aponte JJ, Aide P, Nhabomba AJ, Dobano C, et al. Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS,S\/AS02 in Mozambique. Vaccine. 2014;32:2209\u201316. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2014.02.042\n                    \n                  .","journal-title":"Vaccine."},{"key":"1378_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12916-019-1277-x","volume":"17","author":"L Kurtovic","year":"2019","unstructured":"Kurtovic L, Agius PA, Feng G, Drew DR, Ubillos I, Sacarlal J, et al. Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure. BMC Med. 2019;17:45. \n                    https:\/\/doi.org\/10.1186\/s12916-019-1277-x\n                    \n                  .","journal-title":"BMC Med"},{"key":"1378_CR31","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0140-6736(05)66418-5","volume":"365","author":"D Schellenberg","year":"2005","unstructured":"Schellenberg D, Menendez C, Aponte JJ, Kahigwa E, Tanner M, Mshinda H, et al. Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet England. 2005;365:1481\u20133. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(05)66418-5\n                    \n                  .","journal-title":"Lancet England"},{"key":"1378_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1475-2875-6-161","volume":"6","author":"CJ Sutherland","year":"2007","unstructured":"Sutherland CJ, Drakeley CJ, Schellenberg D. How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions? Malar J. 2007;6:161. \n                    https:\/\/doi.org\/10.1186\/1475-2875-6-161\n                    \n                  .","journal-title":"Malar J"},{"key":"1378_CR33","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1128\/CVI.00044-08","volume":"15","author":"D Quelhas","year":"2008","unstructured":"Quelhas D, Puyol L, Quinto L, Serra-Casas E, Nhampossa T, Macete E, et al. Impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on antibody responses to erythrocytic-stage Plasmodium falciparum antigens in infants in Mozambique. Clin Vaccine Immunol. 2008;15:1282\u201391. \n                    https:\/\/doi.org\/10.1128\/CVI.00044-08\n                    \n                  .","journal-title":"Clin Vaccine Immunol"},{"key":"1378_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4269\/ajtmh.2003.68.61","volume":"68","author":"SK Kariuki","year":"2003","unstructured":"Kariuki SK, ter Kuile FO, Wannemuehler K, Terlouw DJ, Kolczak MS, Hawley WA, et al. Effects of permethrin-treated bed nets on immunity to malaria in western Kenya I. Antibody responses in pregnant women and cord blood in an area of intense malaria transmission. Am J Trop Med Hyg. 2003;68:61\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"1378_CR35","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1056\/NEJMoa1008115","volume":"365","author":"MA Thera","year":"2011","unstructured":"Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Ouattara A, Kone AK, et al. A field trial to assess a blood-stage malaria vaccine. N Engl J Med. 2011;365:1004\u201313. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1008115\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1378_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1128\/CVI.05523-11","volume":"19","author":"C Doba\u00f1o","year":"2012","unstructured":"Doba\u00f1o C, Quelhas D, Quint\u00f3 L, Puyol L, Serra-Casas E, Mayor A, et al. Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children. Clin Vaccine Immunol. 2012;19:157\u201366. \n                    https:\/\/doi.org\/10.1128\/CVI.05523-11\n                    \n                  .","journal-title":"Clin Vaccine Immunol"},{"key":"1378_CR37","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/76272","volume":"6","author":"DJ Conway","year":"2000","unstructured":"Conway DJ, Cavanagh DR, Tanabe K, Roper C, Mikes ZS, Sakihama N, et al. A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat Med. 2000;6:689\u201392. \n                    https:\/\/doi.org\/10.1038\/76272\n                    \n                  .","journal-title":"Nat Med"},{"key":"1378_CR38","doi-asserted-by":"publisher","first-page":"e101737","DOI":"10.1371\/journal.pone.0101737","volume":"9","author":"R Perraut","year":"2014","unstructured":"Perraut R, Joos C, Sokhna C, Polson HEJ, Trape J-F, Tall A, et al. Association of antibody responses to the conserved Plasmodium falciparum merozoite surface protein 5 with protection against clinical malaria. PLoS One. 2014;9:e101737. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0101737\n                    \n                  .","journal-title":"PLoS One"},{"key":"1378_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-13-608","volume":"13","author":"MM Medeiros","year":"2013","unstructured":"Medeiros MM, Fotoran WL, dalla Martha RC, Katsuragawa TH, Pereira da Silva LH, Wunderlich G. Natural antibody response to Plasmodium falciparum merozoite antigens MSP5, MSP9 and EBA175 is associated to clinical protection in the Brazilian Amazon. BMC Infect Dis. 2013;13:1\u201319. \n                    https:\/\/doi.org\/10.1186\/1471-2334-13-608\n                    \n                  .","journal-title":"BMC Infect Dis"},{"key":"1378_CR40","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/cid\/cix837","volume":"66","author":"A Valmaseda","year":"2018","unstructured":"Valmaseda A, Macete E, Nhabomba A, Guinovart C, Aide P, Bardaji A, et al. Identifying immune correlates of protection against Plasmodium falciparum through a novel approach to account for heterogeneity in malaria exposure. Clin Infect Dis. 2018;66:586\u201393. \n                    https:\/\/doi.org\/10.1093\/cid\/cix837\n                    \n                  .","journal-title":"Clin Infect Dis"},{"key":"1378_CR41","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1128\/IAI.00048-09","volume":"77","author":"W-H Tham","year":"2009","unstructured":"Tham W-H, Wilson DW, Reiling L, Chen L, Beeson JG, Cowman AF. Antibodies to reticulocyte binding protein-like homologue 4 inhibit invasion of Plasmodium falciparum into human erythrocytes. Infect Immun. 2009;77:2427\u201335. \n                    https:\/\/doi.org\/10.1128\/IAI.00048-09\n                    \n                  .","journal-title":"Infect Immun"},{"key":"1378_CR42","doi-asserted-by":"publisher","first-page":"e45253","DOI":"10.1371\/journal.pone.0045253","volume":"7","author":"L Reiling","year":"2012","unstructured":"Reiling L, Richards JS, Fowkes FJI, Wilson DW, Chokejindachai W, Barry AE, et al. The Plasmodium falciparum erythrocyte invasion ligand pfrh4 as a target of functional and protective human antibodies against malaria. PLoS One. 2012;7:e45253 Available: \n                    https:\/\/doi.org\/10.1371\/journal.pone.0045253\n                    \n                  .","journal-title":"PLoS One"},{"key":"1378_CR43","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1038\/ncomms3836","volume":"4","author":"KJ Ewer","year":"2013","unstructured":"Ewer KJ, O\u2019Hara GA, Duncan CJA, Collins KA, Sheehy SH, Reyes-Sandoval A, et al. Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation. Nat Commun. 2013;4:2836. \n                    https:\/\/doi.org\/10.1038\/ncomms3836\n                    \n                  .","journal-title":"Nat Commun"},{"key":"1378_CR44","doi-asserted-by":"publisher","first-page":"785","DOI":"10.4049\/jimmunol.1300444","volume":"191","author":"KEM Persson","year":"2013","unstructured":"Persson KEM, Fowkes FJI, McCallum FJ, Gicheru N, Reiling L, Richards JS, et al. Erythrocyte-binding antigens of Plasmodium falciparum are targets of human inhibitory antibodies and function to evade naturally acquired immunity. J Immunol. 2013;191:785\u201394. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1300444\n                    \n                  .","journal-title":"J Immunol"},{"key":"1378_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pt.2011.10.002","volume":"28","author":"W-H Tham","year":"2012","unstructured":"Tham W-H, Healer J, Cowman AF. Erythrocyte and reticulocyte binding-like proteins of Plasmodium falciparum. Trends Parasitol. 2012;28:23\u201330. \n                    https:\/\/doi.org\/10.1016\/j.pt.2011.10.002\n                    \n                  .","journal-title":"Trends Parasitol"},{"key":"1378_CR46","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.1128\/IAI.72.10.5840-5849.2004","volume":"72","author":"MW Goschnick","year":"2004","unstructured":"Goschnick MW, Black CG, Kedzierski L, Holder AA, Coppel RL. Merozoite surface protein 4\/5 provides protection against lethal challenge with a heterologous malaria parasite strain. Infect Immun. 2004;72:5840\u20139. \n                    https:\/\/doi.org\/10.1128\/IAI.72.10.5840-5849.2004\n                    \n                  .","journal-title":"Infect Immun"},{"key":"1378_CR47","doi-asserted-by":"publisher","first-page":"6034","DOI":"10.1128\/IAI.68.10.6034-6037.2000","volume":"68","author":"L Kedzierski","year":"2000","unstructured":"Kedzierski L, Black CG, Coppel RL. Immunization with recombinant Plasmodium yoelii merozoite surface protein 4\/5 protects mice against lethal challenge. Infect Immun. 2000;68:6034\u20137.","journal-title":"Infect Immun"},{"key":"1378_CR48","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science.1087025","volume":"301","author":"KG Le Roch","year":"2003","unstructured":"Le Roch KG, Zhou Y, Blair PL, Grainger M, Moch JK, Haynes JD, et al. Discovery of gene function by expression profiling of the malaria parasite life cycle. Science. 2003;301:1503\u20138. \n                    https:\/\/doi.org\/10.1126\/science.1087025\n                    \n                  .","journal-title":"Science."},{"key":"1378_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","volume":"386","author":"The RTS,S Clinical Trials Partnership","year":"2015","unstructured":"The RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015;386:31\u201345. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(15)60721-8\n                    \n                  .","journal-title":"Lancet."},{"key":"1378_CR50","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1515257","volume":"374","author":"A Olotu","year":"2016","unstructured":"Olotu A, Fegan G, Wambua J, Nyangweso G, Leach A, Lievens M, et al. Seven-year efficacy of RTS,S\/AS01 malaria vaccine among young African children. N Engl J Med. 2016;374:2519\u201329. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1515257\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1378_CR51","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.1371\/journal.pmed.0040242","volume":"4","author":"JJ Aponte","year":"2007","unstructured":"Aponte JJ, Menendez C, Schellenberg D, Kahigwa E, Mshinda H, Vountasou P, et al. Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation. PLoS Med. 2007;4:e242. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.0040242\n                    \n                  .","journal-title":"PLoS Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-019-1378-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-019-1378-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-019-1378-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T19:17:27Z","timestamp":1597259847000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-019-1378-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,14]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1378"],"URL":"https:\/\/doi.org\/10.1186\/s12916-019-1378-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736423511.793573188","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,14]]},"assertion":[{"value":"20 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committees from Spain, Mozambique, and Ghana, and written informed consent was obtained from parents or guardians before starting study procedures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}